Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-08 3:14 pm Sale |
2025-03-31 | 13G | Aprea Therapeutics, Inc. APRE |
Sio Capital Management, LLC | 276,603 5.040% |
-3,397 (-1.21%) |
Filing History |
| 2025-02-13 12:15 pm Sale |
2024-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Stonepine Capital Management, LLC | 286,395 5.100% |
-79,041 (-21.63%) |
Filing History |
| 2025-02-10 12:56 pm Purchase |
2024-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Sio Capital Management, LLC | 276,603 5.090% |
276,603 (New Position) |
Filing History |
| 2025-02-10 08:36 am Purchase |
2024-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
HIRSCHMAN ORIN | 539,300 9.900% |
190,000 (+54.39%) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Aprea Therapeutics, Inc. APRE |
Nantahala Capital Management, LLC | 411,520 7.300% |
411,520 (New Position) |
Filing History |
| 2024-10-10 4:07 pm Purchase |
2024-10-07 | 13G | Aprea Therapeutics, Inc. APRE |
Stonepine Capital Management, LLC | 365,436 6.600% |
365,436 (New Position) |
Filing History |
| 2024-02-14 08:00 am Purchase |
2023-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Sio Capital Management, LLC | 280,000 7.490% |
280,000 (New Position) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
HIRSCHMAN ORIN | 349,300 11.000% |
4,300 (+1.25%) |
Filing History |
| 2023-03-03 06:03 am Purchase |
2023-02-23 | 13G | Aprea Therapeutics, Inc. APRE |
HIRSCHMAN ORIN | 345,000 11.000% |
345,000 (New Position) |
Filing History |
| 2022-11-15 5:08 pm Unchanged |
2022-10-26 | 13D | Aprea Therapeutics, Inc. APRE |
HealthCap VII L.P. | 118,305 4.500% |
0 (Unchanged) |
Filing History |
| 2022-06-30 4:34 pm Unchanged |
2022-06-30 | 13D | Aprea Therapeutics, Inc. APRE |
HealthCap VII L.P. | 118,305 10.100% |
0 (Unchanged) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Redmile Group LLC | 0 0.000% |
-63,436 (Position Closed) |
Filing History |
| 2022-02-10 8:44 pm Sale |
2021-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Versant Ventures V LLC | 0 0.000% |
-58,777 (Position Closed) |
Filing History |
| 2021-10-15 4:50 pm Unchanged |
2021-10-13 | 13D | Aprea Therapeutics, Inc. APRE |
HealthCap VII L.P. | 118,305 11.200% |
0 (Unchanged) |
Filing History |
| 2021-10-12 4:18 pm Sale |
2021-09-30 | 13G | Aprea Therapeutics, Inc. APRE |
MORGAN STANLEY MS |
9,248 0.900% |
-44,372 (-82.75%) |
Filing History |
| 2021-03-24 5:13 pm Purchase |
2021-03-15 | 13G | Aprea Therapeutics, Inc. APRE |
MORGAN STANLEY MS |
53,621 5.100% |
53,621 (New Position) |
Filing History |
| 2021-02-16 5:08 pm Sale |
2021-02-11 | 13D | Aprea Therapeutics, Inc. APRE |
5AM Ventures IV L.P. | 30,958 13.000% |
-37,925 (-55.06%) |
Filing History |
| 2021-02-16 4:06 pm Sale |
2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Redmile Group LLC | 63,436 5.990% |
-50,000 (-44.08%) |
Filing History |
| 2021-02-16 07:32 am Sale |
2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Versant Ventures V LLC | 58,777 5.500% |
-67,189 (-53.34%) |
Filing History |
| 2021-02-16 06:51 am Sale |
2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
KDev Investments AB | 89,035 8.400% |
-33,207 (-27.17%) |
Filing History |